clinical trial · NCT07690228
A Study of GSM-779690T in Healthy Adult Participants
Healthy Adult ParticipantsAlzheimer DiseaseGSM-779690TPlacebo
brief summary
A Phase 1, single-centre, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a single and multiple dose regimens of GSM-779690T in healthy adults. This first-in-human study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GSM-779690T.
started
Aug 15, 2026
primary completion
Aug 15, 2026
completion
Jul 15, 2027
last updated
Jul 9, 2026
official title
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacology of GSM-779690T in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol